Skip to main content

Table 1 Anthropometric characteristics and pulmonary function

From: New strategies of physical activity assessment in cystic fibrosis: a pilot study

Characteristics All CF (n = 24) Device 1 (n = 6) Device 2 (n = 6) Device 3 (n = 6) Device 4 (n = 6)
Age, yr 37.6 ± 11.5 33.2 ± 12.1 38.3 ± 8.4 40.7 ± 12.3 38.2 ± 14.3
BMI, Kg/ m2 22.9 ± 3.2 24.4 ± 2.5 20.8 ± 4.0 23.6 ± 2.1 22.9 ± 3.6
FEV1, % predicted 58.3 ± 19.4 73.2 ± 15.0 52.7 ± 17.1 51.5 ± 11.7 56 ± 26.8
FVC, %predicted 75.7 ± 18.2 88.3 ± 17.0 68.3 ± (15.0) 76.2 ± 14.1 69.8 ± 22.7
Pseudomonas aeruginosa colonization, n (%) 16 (66.7) 3 (50.0) 5 (83.3) 5 (83.3) 3 (50.0)
Staphylococcus aureus colonization, n (%) 9 (37.5) 3 (50.0) 2 (33.3) 1 (16.7) 3 (50.0)
Burkholderia cepacia colonization, n (%) 2 (8.3) 1 (16.7) 0 0 1 (16.7)
Pancreatic insufficiency, n (%) 21 (87.5) 5 (83.3) 5 (83.3) 6 (100.0) 5 (83.3)
CF-related diabetes, n (%) 7 (29.2) 1 1 3 2
F508del Homozygous/Heterozygous 8/15 1/5 4/2 2/4 1/4
  1. Data are presented as mean ± SD, unless otherwise stated. *P <  0.05, differences between CF groups. Abbreviations: BMI body mass index, FEV1 Forced expiratory volume in 1 s, FVC forced vital capacity, Device 1 Smartwatch, Device 2 Fitbit, Device 3 Smartphone (Android), Device 4 Smartphone (iOS)